Decision: Advertising Investigations: December 2025
Decisions made by the MHRA following investigations into complaints about advertising for licensed medicines.
-
-
Aurobindo Pharma USA Inc – 05/15/2024
Aurobindo Pharma USA Inc – 05/15/2024. Country: United States. Record Type: 483 -
Gusto Group Inc. Recalls Shrimp Paste (Klong Kone) ‘’454 G. (1 LBS)’ and ‘910 G. (2 LBS)’ because of Possible Health Risk
Gusto Group Inc. of Paterson, NJ is recalling [Klong Kone] Shrimp Paste (Klong Kone) ‘454 G. (1 LBS)’ and ‘910 G. (2 LBS)’ because it has the potential to be contaminated with elevated levels of lead. Short term exposures to very low levels of lead may not elicit any symptoms. It is possible that -
FDA In Brief: FDA provides guidance on improving the agency’s interactions with product developers to make the drug development process more informed and efficient
FDA announces two new guidances to support enhanced communication with drug developers, help make the development process more informed and efficient -
FDA Approves First Over-the-Counter Naloxone Nasal Spray
The U.S. Food and Drug Administration approved the first naloxone nasal spray product available without a prescription. -
FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose
The U.S. Food and Drug Administration approved Opvee, the first nalmefene hydrochloride nasal spray for the emergency treatment of known or suspected opioid overdose in adults and pediatric patients 12 years of age and older -
Richie Pharmacal Company, Inc – 12/12/2024
Richie Pharmacal Company, Inc – 12/12/2024. Country: United States. Record Type: 483 -
Gilead Issues Voluntary Nationwide Recall of One Lot of Veklury (Remdesivir) for Injection 100 mg/vial Due to the Presence of a Glass Particle
Foster City, Calif., September 20, 2024 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is issuing a voluntary recall of one lot of Veklury® (remdesivir) for Injection 100 mg/vial, to the consumer level. Gilead received a customer complaint and confirmed the presence of a glass particle in -
Sterling Distributors, LLC – 03/06/2025
Sterling Distributors, LLC – 03/06/2025. Country: United States. Record Type: 483 -
Pure Indulgence Aesthetics – 12/12/2025
Pure Indulgence Aesthetics – 12/12/2025. Country: United States. Record Type: 483 -
A2A integrated Logistics Inc – 02/24/2025
A2A integrated Logistics Inc – 02/24/2025. Country: United States. Record Type: 483 -
Research: Improving information supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z-Drugs
Public Assessment Report on improving information regarding addiction, dependence, withdrawal, and tolerance for gabapentin, pregabalin, benzodiazepines, and z-drugs.